Abstract Background Anti-androgen resistance remains a major clinical challenge in the treatment of prostate cancer (PCa). leading to disease progression and treatment failure. Despite extensive research on resistance mechanisms. a reliable prognostic model for predicting patient outcomes and guiding therapeutic strategies is still lacking. https://www.popularfilm.blog/